Amgen: FDA Approves Tezspire For Chronic Rhinosinusitis With Nasal Polyps

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- ...
Medical Dialogues

AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps

AstraZeneca and Amgen's Tezspire (tezepelumab) has been approved in the US for the add-on maintenance treatment of adult and ...

US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease

The U. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...

FDA Approves Amgen and AstraZeneca Treatment for Nasal Polyps Condition

The FDA approved Amgen's and AstraZeneca's drug to treat chronic rhinosinusitis with nasal polyps, an inflammatory condition of the sinuses and nasal passages. The companies said the approval was ...

TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Winter’s here and so is the stuffy nose: 5 nighttime drinks that stop nasal congestion without medicines

Winter congestion can disrupt sleep, but certain bedtime drinks offer relief. Warm turmeric milk, ginger and honey tea, steam ...